Investors may be familiar with more prominent drug developers, but this small-cap biotech shouldn't be overlooked.

Jim Cramer says we haven't reached the market bottom, but he sees opportunities among the bank stocks after their earnings reports.

Moderna said its current vaccine will be a 'first line of defense' against the rapidly-spreading Omicron variant.

Moderna posted early-stage data from its developing flu vaccine, as investors await an update on the efficacy of its Covid vaccine against the newly-identified Omicron variant.

Sanofi says its COVID vaccine candidate has positive test results, but the company is ready to drop its development because of the Moderna and Pfizer vaccines.

General Mills, Citrix Systems, Kadmon, ICU Medical and Global Payments are five top stocks for Wednesday.

The purchase of Kadmon is designed to boost Sanofi’s transplant business. Sanofi shares dipped and Kadmon's jumped.

Under Armour, ZoomInfo, Translate Bio, Outlook Therapeutics and Arcturus Therapeutics are five top gainers for Tuesday.

Stocks moving in premarket trading Tuesday include Under Armour, Alibaba, Clorox, Take-Two and Translate Bio.

The online retail giant had a plan to own your living room. It didn't work because AI-powered voice assistants don't work.

The new variant may be even more magically delicious.

Twitter is desperate for revenue. It has a $13 billion debt burden, but hasn’t showed a profit for eight of the last 10 years.